Below are the most recent publications written about "Dyslipidemias" by people in Profiles.
-
Zghebi SS, Rutter MK, Sun LY, Ullah W, Rashid M, Ashcroft DM, Steinke DT, Weng S, Kontopantelis E, Mamas MA. Comorbidity clusters and in-hospital outcomes in patients admitted with acute myocardial infarction in the USA: A national population-based study. PLoS One. 2023; 18(10):e0293314.
-
Williams L, Baker-Smith CM, Bolick J, Carter J, Kirkpatrick C, Ley SL, Peterson AL, Shah AS, Sikand G, Ware AL, Wilson DP. Nutrition interventions for youth with dyslipidemia: a National Lipid Association clinical perspective. J Clin Lipidol. 2022 Nov-Dec; 16(6):776-796.
-
Davis SM, Nokoff NJ, Furniss A, Pyle L, Valentine A, Fechner P, Ikomi C, Magnusen B, Nahata L, Vogiatzi MG, Dempsey A. Population-based Assessment of Cardiometabolic-related Diagnoses in Youth With Klinefelter Syndrome: A PEDSnet Study. J Clin Endocrinol Metab. 2022 04 19; 107(5):e1850-e1859.
-
Dokollari A, S? MP, Sicouri S, Ramlawi B, Torregrossa G, Bonacchi M. Commentary: Osteogenic Metaplasia of the Aortic Valve. Do Bacteria, Diabetes, and Dyslipidemia Play a Role? Semin Thorac Cardiovasc Surg. 2022; 34(4):1178-1179.
-
Chacko SR, DeJoy R, Lo KB, Albano J, Peterson E, Bhargav R, Gu F, Salacup G, Pelayo J, Azmaiparashvili Z, Rangaswami J, Patarroyo-Aponte G, Benzaquen S, Gupta E. Association of Pre-Admission Statin Use With Reduced In-Hospital Mortality in COVID-19. Am J Med Sci. 2021 06; 361(6):725-730.
-
Kelly MS, Sulaica EM, Beavers CJ. Role of Bempedoic Acid in Dyslipidemia Management. J Cardiovasc Pharmacol. 2020 10; 76(4):376-388.
-
Karalis DG. Editorial commentary: Advances in the management of dyslipidemia: The future is bright, but what we do today is what matters most. Trends Cardiovasc Med. 2021 10; 31(7):425-426.
-
Board C, Kelly MS, Shapiro MD, Dixon DL. PCSK9 Inhibitors in Secondary Prevention-An Opportunity for Personalized Therapy. J Cardiovasc Pharmacol. 2020 05; 75(5):410-420.
-
Trieb M, Kornej J, Knuplez E, Hindricks G, Thiele H, Sommer P, Scharnagl H, Dagres N, Dinov B, Bollmann A, Husser D, Marsche G, Buettner P. Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number. Basic Res Cardiol. 2019 05 08; 114(4):27.
-
Kang EY, Chen TH, Garg SJ, Sun CC, Kang JH, Wu WC, Hung MJ, Lai CC, Cherng WJ, Hwang YS. Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy. JAMA Ophthalmol. 2019 04 01; 137(4):363-371.